Literature DB >> 7326067

Permeability of rheumatoid and normal human synovium to specific plasma proteins.

J R Levick.   

Abstract

A method is described for the determination of the permeability of the blood-joint barrier to specific plasma proteins, using the ratio of protein concentration in synovial fluid to that in plasma. The inadequacy of the ratio per se as a direct index of permeability is discussed. Permeabilities are evaluated for the normal and rheumatoid human knee. Permeability increases in the rhematoid knee by approximately 6 times for the rheumatoid knee by approximately 6 times for albumin and over 40 times for macroglobulins. The effect of protein molecular dimensions upon permeability is analyzed. Permeability shows less dependence upon solute dimensions in the rheumatoid knee than in the normal knee, i.e., molecular selectivity is reduced. From these data and synovial morphology, a two-membrane model of the blood-joint barrier is developed. The relative contribution of the component intimal and endothelial layers to the total barrier is found to depend upon solute dimensions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7326067     DOI: 10.1002/art.1780241215

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  42 in total

Review 1.  Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.

Authors:  R O Day; A J McLachlan; G G Graham; K M Williams
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

Review 2.  Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid.

Authors:  P Netter; B Bannwarth; M J Royer-Morrot
Journal:  Clin Pharmacokinet       Date:  1989-09       Impact factor: 6.447

3.  Inhibition of myeloperoxidase by synovial fluid and serum.

Authors:  B Dularay; C M Yea; C J Elson
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

4.  The human knee: A window on the microvasculature.

Authors:  Peter A Simkin
Journal:  Tissue Barriers       Date:  2015-04-03

Review 5.  Cellular and molecular perspectives in rheumatoid arthritis.

Authors:  Douglas J Veale; Carl Orr; Ursula Fearon
Journal:  Semin Immunopathol       Date:  2017-05-15       Impact factor: 9.623

6.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

Review 7.  Development of macromolecular prodrug for rheumatoid arthritis.

Authors:  Fang Yuan; Ling-dong Quan; Liao Cui; Steven R Goldring; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

8.  Reduced systemic IgG levels against peptidoglycan in rheumatoid arthritis (RA) patients.

Authors:  I A Schrijver; Y A De Man; M J Melief; J M Van Laar; H M Markusse; I S Klasen; M P Hazenberg; J D Laman
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

9.  [Methotrexate in rheumatology].

Authors:  C Fiehn
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

10.  In vivo role of phagocytic synovial lining cells in onset of experimental arthritis.

Authors:  P L Van Lent; A E Van den Hoek; L A Van den Bersselaar; M F Spanjaards; N Van Rooijen; C D Dijkstra; L B Van de Putte; W B Van den Berg
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.